143 related articles for article (PubMed ID: 7891485)
1. Renal function during antihypertensive treatment.
Madhavan S; Stockwell D; Cohen H; Alderman MH
Lancet; 1995 Mar; 345(8952):749-51. PubMed ID: 7891485
[TBL] [Abstract][Full Text] [Related]
2. Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group.
Walker WG; Neaton JD; Cutler JA; Neuwirth R; Cohen JD
JAMA; 1992 Dec; 268(21):3085-91. PubMed ID: 1433739
[TBL] [Abstract][Full Text] [Related]
3. Nocturnal blood pressure in treated hypertensive African Americans Compared to treated hypertensive European Americans.
Hebert LA; Agarwal G; Ladson-Wofford SE; Reif M; Hiremath L; Carlton SG; Nahman NS; Falkenhain ME; Agarwal A
J Am Soc Nephrol; 1996 Oct; 7(10):2130-4. PubMed ID: 8915972
[TBL] [Abstract][Full Text] [Related]
4. Ethnicity and renal disease: lessons from the Multiple Risk Factor Intervention Trial and the Treatment of Mild Hypertension Study.
Flack JM; Neaton JD; Daniels B; Esunge P
Am J Kidney Dis; 1993 Apr; 21(4 Suppl 1):31-40. PubMed ID: 8465834
[TBL] [Abstract][Full Text] [Related]
5. The association of blood pressure levels and change in renal function in hypertensive and nonhypertensive subjects.
Rosansky SJ; Hoover DR; King L; Gibson J
Arch Intern Med; 1990 Oct; 150(10):2073-6. PubMed ID: 2222092
[TBL] [Abstract][Full Text] [Related]
6. Racial differences in the renal response to blood pressure lowering during chronic angiotensin-converting enzyme inhibition: a prospective double-blind randomized comparison of fosinopril and lisinopril in older hypertensive patients with chronic renal insufficiency.
Mitchell HC; Smith RD; Cutler RE; Sica D; Videen J; Thompsen-Bell S; Jones K; Bradley-Guidry C; Toto RD
Am J Kidney Dis; 1997 Jun; 29(6):897-906. PubMed ID: 9186076
[TBL] [Abstract][Full Text] [Related]
7. Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
Voyaki SM; Staessen JA; Thijs L; Wang JG; Efstratopoulos AD; Birkenhäger WH; de Leeuw PW; Leonetti G; Nachev C; Rodicio JL; Tuomilehto J; Fagard R;
J Hypertens; 2001 Mar; 19(3):511-9. PubMed ID: 11288822
[TBL] [Abstract][Full Text] [Related]
8. Renal function during antihypertensive treatment.
Janssen WM; de Zeeuw D; de Jong PE
Lancet; 1995 Jul; 346(8968):193. PubMed ID: 7661981
[No Abstract] [Full Text] [Related]
9. Does treated primary hypertension lead to end-stage renal disease? A 20-year follow-up of the Primary Prevention Study in Göteborg, Sweden.
Siewert-Delle A; Ljungman S; Andersson OK; Wilhelmsen L
Nephrol Dial Transplant; 1998 Dec; 13(12):3084-90. PubMed ID: 9870470
[TBL] [Abstract][Full Text] [Related]
10. Overlap between whites and blacks in response to antihypertensive drugs.
Sehgal AR
Hypertension; 2004 Mar; 43(3):566-72. PubMed ID: 14757779
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of losartan in hypertensive patients with renal impairment. Collaborative Group.
Toto R; Shultz P; Raij L; Mitchell H; Shaw W; Ramjit D; Toh J; Shahinfar S
Hypertension; 1998 Feb; 31(2):684-91. PubMed ID: 9461241
[TBL] [Abstract][Full Text] [Related]
12. Black-White Difference in the Impact of Long-Term Blood Pressure From Childhood on Adult Renal Function: The Bogalusa Heart Study.
Yan Y; Zhang T; Li S; Liu Y; Bazzano L; He J; Mi J; Chen W
Am J Hypertens; 2018 Nov; 31(12):1300-1306. PubMed ID: 30010953
[TBL] [Abstract][Full Text] [Related]
13. [Effect of arterial pressure and age on renal function, The "Care for the Kidney" study].
Olivares J; Guillén F; Sánchez JJ; Morales-Olivas FJ
Nefrologia; 2003; 23(2):137-44. PubMed ID: 12778878
[TBL] [Abstract][Full Text] [Related]
14. A study on the outcome of percutaneous transluminal renal angioplasty in patients with renal failure.
Roussos L; Christensson A; Thompson O
Nephron Clin Pract; 2006; 104(3):c132-42. PubMed ID: 16899992
[TBL] [Abstract][Full Text] [Related]
15. Renal outcomes in hypertensive Black patients at high cardiovascular risk.
Weir MR; Bakris GL; Weber MA; Dahlof B; Devereux RB; Kjeldsen SE; Pitt B; Wright JT; Kelly RY; Hua TA; Hester RA; Velazquez E; Jamerson KA
Kidney Int; 2012 Mar; 81(6):568-76. PubMed ID: 22189843
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group.
Shulman NB; Ford CE; Hall WD; Blaufox MD; Simon D; Langford HG; Schneider KA
Hypertension; 1989 May; 13(5 Suppl):I80-93. PubMed ID: 2490833
[TBL] [Abstract][Full Text] [Related]
17. Variation in the progression of diabetic nephropathy according to racial origin.
Earle KK; Porter KA; Ostberg J; Yudkin JS
Nephrol Dial Transplant; 2001 Feb; 16(2):286-90. PubMed ID: 11158401
[TBL] [Abstract][Full Text] [Related]
18. Low-level lead exposure, renal function and blood pressure.
Staessen J
Verh K Acad Geneeskd Belg; 1995; 57(6):527-74. PubMed ID: 8686371
[TBL] [Abstract][Full Text] [Related]
19. Irbesartan effects on renal function in patients with renal impairment and hypertension: a drug-withdrawal study.
De Rosa ML; de Cristofaro A; Rossi M; Baiano A; Cardace P; Albanese L; Vigorito C
J Cardiovasc Pharmacol; 2001 Sep; 38(3):482-9. PubMed ID: 11486253
[TBL] [Abstract][Full Text] [Related]
20. Black-white differences in electrocardiographic left ventricular mass and its association with blood pressure (the ARIC study). Atherosclerosis Risk in Communities.
Arnett DK; Rautaharju P; Crow R; Folsom AR; Ekelund LG; Hutchinson R; Tyroler HA; Heiss G
Am J Cardiol; 1994 Aug; 74(3):247-52. PubMed ID: 8037129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
